Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Clinica Baviera (CBAV) Stock Price & Analysis

9 Followers

CBAV Stock Chart & Stats

€52.00-€0.80(1.17%)
At close: 5:30 PM GMT+1
€52.5€55€57.5€60Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 51.60 - EUR 52.80
52-Week Range
EUR 40.10 - EUR 62.00
Previous Close
EUR 51.40
Volume
N/A
Average Volume (3M)
2,416
Market Cap
EUR 847.78M
Enterprise Value
EUR 882.45M
Total Cash (Recent Filing)
EUR 51.59M
Total Debt (Recent Filing)
EUR 9.90M
Price to Earnings (P/E)
18.6
Beta
0.46
Next Earnings
Jul 27, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jun 10, 2026
Dividend Yield
3.02%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Sustained revenue expansion indicates that Clinica Baviera has continued to grow its ophthalmology business across several annual periods. Continued top-line progress supports clinic utilization, strengthens the operating platform, and provides a durable base for future earnings growth.

Strong Profitability

Consistently strong net margins and solid operating profitability show that revenue growth is translating into meaningful earnings rather than merely expanding the cost base. This profitability can support reinvestment, resilience, and continued value creation over the next several quarters.

Improved Balance Sheet

Material deleveraging and very low debt relative to equity improve financial flexibility and reduce the balance-sheet burden on the business. Higher equity alongside asset growth further supports stability, giving Clinica Baviera more capacity to sustain operations and fund priorities.

Bears Say

Margin Volatility

Recent margin changes introduce uncertainty about how much of the company’s revenue growth will convert into operating profit. Whether caused by mix, accounting differences, or cost and price pressure, continued volatility could make earnings progression less predictable over coming periods.

Moderate Free Cash Flow Conversion

Although operating cash flow is healthy and free cash flow remains positive, only moderate conversion of net income into free cash indicates that reinvestment needs or working-capital movements absorb part of reported earnings. This can limit internally available cash for expansion or distributions.

Deleveraging Durability Needs Confirmation

The current balance sheet is much stronger, but the company’s history of materially higher leverage means the improvement is not yet fully proven as a permanent change. Any reversal toward prior debt levels could reduce financial flexibility and make earnings quality more dependent on balance-sheet discipline.

Clinica Baviera News

CBAV FAQ

What was Clinica Baviera’s price range in the past 12 months?
Clinica Baviera lowest stock price was €40.10 and its highest was €62.00 in the past 12 months.
What is Clinica Baviera’s market cap?
Clinica Baviera’s market cap is €847.78M.
When is Clinica Baviera’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clinica Baviera’s earnings last quarter?
Clinica Baviera released its earnings results on Jul 29, 2026. The company reported €0.747 earnings per share for the quarter.
Is Clinica Baviera overvalued?
According to Wall Street analysts Clinica Baviera’s price is currently Undervalued.
Does Clinica Baviera pay dividends?
Clinica Baviera pays an annual dividend of €1.568 which represents an annual dividend yield of 3.02%. See more information on Clinica Baviera dividends here
What is Clinica Baviera’s EPS estimate?
Clinica Baviera’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinica Baviera have?
Clinica Baviera has 16,307,580 shares outstanding.
What happened to Clinica Baviera’s price movement after its last earnings report?
Clinica Baviera reported an EPS of €0.747 in its last earnings report. Following the earnings report the stock price went up 0.38%.
Which hedge fund is a major shareholder of Clinica Baviera?
Currently, no hedge funds are holding shares in ES:CBAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology